Penumbra
PEN
$278.77
Share price
0.56%
Change (1 day)
35.52%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.
Penumbra (PEN) - Total debt
Total debt on the balance sheet as of December 2024 : $0.22 Billion USD
According to Penumbra's latest financial reports the company's total debt is $0.22 Billion USD. A company’s total debt is the sum of all current and non-current debts.
Penumbra - Total debt on balance sheet (from 2018 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | $0.22 B | -4.67% |
| 2023-12-31 | $0.23 B | -0.61% |
| 2022-12-31 | $0.23 B | 35.85% |
| 2021-12-31 | $0.17 B | 124.58% |
| 2020-12-31 | $77.27 M | -6.1% |
| 2019-12-31 | $82.29 M | |
| 2018-12-31 | N/A | |
| 2013-12-31 | $6 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | $32.72 M | -85.35% | 🇺🇸 USA |
 | $0.79 B | 255.73% | 🇺🇸 USA |